Reuters logo
BRIEF-Endologix reports positive clinical data from nellix Evas Forward-IDE study
May 26, 2016 / 1:22 PM / a year ago

BRIEF-Endologix reports positive clinical data from nellix Evas Forward-IDE study

May 26 (Reuters) - Endologix Inc

* Reports positive clinical data from nellix Evas Forward-IDE study

* IDE study demonstrated that nellix Evas system met study primary endpoints for major adverse events

* Endologix Inc says company remains on track to receive potential FDA approval for nellix evas system at end of 2016 or early 2017 Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1 646 223 8780)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below